MedImmune's FDA Roller Coaster
683054
The firm is having its share of ups and downs, courtesy of everyone's favorite government agency.
87694
FDA clearance sends stock skyrocketing.
545492
Is the US Food &amp; Drug Administration failing? That was the testimony of one senior FDA official last week concerning Merck&#39;s withdrawal of the Vioxx anti-pain drug.
698753
MedImmune Inc.&#39;s cancellation of trials for an arthritis and psoriasis treatment sent the company&#39;s stock lower Monday and helped drag down the entire biotechnology sector.
249661
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
764344
The anti-industry crusader targets pharmaceuticals.
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
262080
There are two problems at the FDA. The first is that the Fraud and Drug Administration clearly puts the protection of Big Pharma profits as its primary mission, rather than protecting the public from dangerous drugs.
177369
FDA panel's safety concerns have sidetracked P&Gs Intrinsa.
214469
Medicines watchdogs are reviewing safety data for an entire class of drugs taken by millions of patients with arthritis and severe pain after the worldwide withdrawal of Merck&#39;s Vioxx last week.
135195
We can&#39;t isolate ourselves from every danger. That was the message from the Food and Drug Administration. We can&#39;t isolate ourselves from the danger of the FDA.
1574
The food and drug administration, the pharmaceuticals regulator in the United States, was yesterday fighting to head off a crisis in confidence among the American public.
328935
SOME of the biggest companies in the drug industry are shivering under an avalanche of bad news. Merck has already been hit hard by the withdrawal of Vioxx, its arthritis drug.
707426
The case of China's former FDA leader highlights the issues facing the country's pharmaceutical industry.
167999
U.S. drug safety regulators are  coming under fire for their response to years of suspicions,  confirmed last week, that arthritis drug Vioxx increased the  risks of heart attacks and strokes.
509369
The storm lashing big pharmaceutical companies over safety concerns about pain treatments such as Celebrex and Vioxx may actually blow some good in the direction of biotech stocks.